Skip to main content
. 2017 Apr 13;8(31):50761–50773. doi: 10.18632/oncotarget.17098

Figure 3. Different expression of the five key lncRNAs between high risk group and low risk group.

Figure 3

(A) CYP4F26P; (B) RP11-108M12.3; (C) RP11-38M8.1; (D) RP11-54H7.4; (E) ZNF503-AS1 *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.000.